5 Results for "

CES2A-IN-2

" in MedChemExpress (MCE) Product Catalog:
Products (5)

5 Results for "CES2A-IN-2" in MCE Product Catalog:

Cat. No.: HY-173267
Research Areas:  

Metabolic Disease Cancer

CES2A-IN-2 (compound 14n) is an orally active, highly specific, irreversible and covalent CES2A inhibitor with an IC50 of 0.04 nM for human CES2A. CES2A-IN-2 covalently binds to CES2A by specifically targeting the catalytic serine residue (Ser-228). CES2A-IN-2 can significantly ameliorate Irinotecan-triggered gut toxicity (ITGT) without diminishing the anti-tumor effects of Irinotecan (HY-16562) in tumor-bearing mice .
loading...
    loading...
Cat. No.: HY-155181
CAS No.: 2994634-52-3
Purity:  98.18%
Research Areas:  

Cancer

CES2-IN-1 (Compound 24) is a reversible and selective CES2 inhibitor (IC50: 6.72 μM for human CES2). CES2-IN-1 reduces the level of CES2 in living cells. CES2-IN-1 is effective against Irinotecan (HY-16562)-induced delayed diarrhea and DSS-induced ulcerative colitis .
loading...
    loading...
Cat. No.: HY-155755
Research Areas:  

Cancer

CES2A-IN-1 (compound 20w) is a potent CES2A inhibitor with an IC50 value of 1.6 nM for human CES2A. CES2A-IN-1, a bysspectin A derivative, shows an approximately 1000-fold improvement over the lead compound bysspectin A .
loading...
    loading...
Cat. No.: HY-176465
CAS No.: 3037959-47-7
Research Areas:  

Inflammation/Immunology

CES2A-IN-3 (Compound 9d) is a potent serine-targeting covalent human carboxylesterase 2A (hCES2A) inhibitor with an IC50 value of 0.12 nM. CES2A-IN-3 is promising for research of diarrhea and ulcerative colitis .
loading...
    loading...
Cat. No.: HY-177198
CAS No.: 1582753-55-6
Research Areas:  

Others

5'-DMT-3'-CE-2'-TBDMS 2-cyanoethoxycarbonyl, 2-(4-nitrophenyl)ethyl-guanosine is a nucleotide analogue used in nucleic acid synthesis.
loading...
    loading...